Introduction
Type 2 diabetes is characterized by high blood-glucose levels attributed to insulin resistance and defective insulin secretion. Pancreatic β cells, which secrete insulin, are sensitive to oxidative stress induced by high glucose levels that can lead to glucotoxicity and eventually, β-cell death [5, 9]. Insulin is a hormone secreted by pancreatic beta cells that maintains blood glucose homeostasis [1]. Persistent hyper-glycemia has toxic effects on the cellular function and structure and increases the apoptosis in type 2 diabetes. This results in reduced insulin secretion, thereby exacerbating diabetes [3, 5]. Hence, to prevent pancreatic β-cell dysfunction and apoptosis, it is important to reduce the oxidative stress and apoptosis caused by hyperglycemia.
Hyperglycemia produces high levels of ROS in the mitochondria, which induce oxidative stress. Antioxidant enzyme systems protect cells from ROS; however, excessive accumulation of oxidants can lead to an imbalance between oxidants and antioxidants [37]. Oxidative stress causes severe damage and can lead to apoptosis [12]. Oxidative stress-sensitive β cells are easily damaged by high glucose levels, causing apoptosis and further reducing insulin secretion [28]. Thus, mitigating pathological apoptosis of β cells impaired by elevated glucose levels is a necessity. Furthermore, reducing glucotoxicity attributed to high glucose levels is also imperative.
Ferulic acid (4-hydroxy-3-methoxycinnamic acid), a hydroxycinnamic acid derived from various seeds, nuts, grains, and vegetables, exists in its free form [11]. It exhibits various pharmacological effects, including anti-inflammatory, anti-microbial, and anticancer activities [7]. Particularly, ferulic acid is considered a superior antioxidant [34]. However, the effects of ferulic acid on pancreatic β-cell dysfunction and survival under high glucose concentrations have not been examined. Therefore, this study investigated whether ferulic acid could protect pancreatic β cells from glucotoxicity attributed to high glucose levels.
Materials and Methods
Materials
Ferulic acid (Fig. 1) was obtained from Sigma-Aldrich (St. Louis, MO, USA). RPMI 1640 medium was acquired from the Welgene Company (Gyeongsan, Gyeongsangbuk-do, Korea), and other chemicals, including fetal bovine serum (FBS), streptomycin, and penicillin, were acquired from Sigma-Aldrich. The insulin enzyme-linked immunosorbent assay (ELISA) kit was acquired from LINCO Research, Inc. (St. Charles, MO, USA).
Fig. 1. Chemical structure of ferulic acid.
Cell culture
INS-1 pancreatic β cells were cultured in RPMI 1640 medium (Welgene), supplemented with 10% FBS, 100 units/ml streptomycin, 100 μg/ml penicillin, and 50 μM beta-mercaptoethanol, at 37°C in a humidified atmosphere containing 5% CO2.
Cell viability assay
Cell viability was confirmed using a colorimetric MTT assay. The cells (2×104) were pretreated with glucose (5.5 or 30 mM) in a 96-well plate for 48 hr, followed by treatment with 0, 1, 5, 10, or 20 µM ferulic acid for 48 hr. This sample treatment was followed for all subsequent experiments. The cells were treated with MTT solution (100 μl) in 96-well plates, and after 4 hr at 37°C, the formazan crystals formed in viable cells were melted with 100 μl of dimethyl sulfoxide. The absorbance of each well was measured at 540 nm using a microplate reader.
Assay to examine intracellular reactive oxygen species (ROS)
Intracellular ROS levels were measured using a dichlorofluorescein assay. After sample treatment, cells were treated with 5 µM of DCF-DA solution and incubated for 30 min. In the presence of radicals, DCF-DA transformed into a fluorescent product that was maintained within the cells. The fluorescence was measured at 530 nm using a fluorescence plate reader (LS-3B; PerkinElmer, Waltham, MA, USA).
Assay to examine lipid peroxidation
Lipid peroxidation was confirmed by thiobarbituric acid reactive substance (TBARS) assay. After sample treatment, the culture supernatants were collected, and 400 μl of TBARS solution was added. The mixture was then boiled at 95°C for 20 min, and the absorbance was measured at 532 nm. TBARS values were calculated as nmol malondialdehyde using a 1,1,3,3-tetraethoxypropane serial dilution curve.
Nitric oxide (NO) assay
NO levels in cell culture supernatants were measured using the Griess reaction. The cell culture supernatant (50 μl) was mixed with an equal volume of Griess reagent [0.1% N-(1-naphthyl)-ethylenediamine and 1% sulfanilamide in 5% phosphoric acid], and the mixture was incubated at room temperature for 10 min. Absorbance was measured at 550 nm using a microplate absorbance reader. A series of known concentrations of sodium nitrite was used as the standards.
Glucose-stimulated insulin secretion (GSIS)
INS-1 cells (2×104 cells/well) were pre-incubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr. Thereafter, the cells were washed, and the cell-culture medium was replaced with fresh medium and incubated for 5 hr. Subsequently, the cells were incubated with ferulic acid (0, 1, 5, 10, or 20 μM) for 48 hr and stimulated with Krebs-Ringer buffer, containing 5 or 25 mM glucose, for 1 hr. Cell media were collected to measure insulin secretion. Insulin secretion was analyzed using an insulin ELISA kit (LINCO Research Inc.).
Western blot analysis
The cells were lysed in a cold lysis buffer containing 250 mM NaCl, 25 mM Tris-HCl, 1%(v/v) NP-40, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and a protease inhibitor cocktail. Protein concentrations were determined using with a BCATM protein assay kit (Bio-Rad, Hercules, CA, USA). Equal amounts of protein (20 μg/lane) were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membranes. Membranes were probed with secondary anti-bodies. Detection was performed using an Enhanced chemiluminescence (ECL) western blotting detection kit (Bio-Rad). Multi Gauge v3.1 was used to quantify relative protein expression (FujiFilm, Tokyo, Japan).
Flow cytometric assessment of apoptosis
Cells were treated with 5.5 mM glucose, 30 mM glucose, or ferulic acid to quantify apoptosis using annexin V/propidium iodide (PI) staining. The cell suspension (100 µl) was treated with 5 µl annexin-V and PI. After 15 min in the dark bath, this mixture was subjoined with 400 µl binding buffer, which was then analyzed by flow cytometry (Becton Dickinson, San Jose, CA, USA).
Statistical analysis
All experiments were conducted in triplicates. Data are presented as mean ± standard deviation (SD). Statistical analyses were conducted using the SAS software (SAS Institute, Inc., Cary, NC, USA). The treatment groups were compared using one-way analysis of variance (ANOVA), followed by a post hoc Duncan’s multiple-range test. Statistical significance threshold was set at p<0.05.
Results
Effect of ferulic acid on cell viability
The effect of ferulic acid on the viability of INS-1 pancreatic β cells was investigated using an MTT assay (Fig. 2). In β cells treated with a high glucose concentration of 30 mM, the viability was significantly lower (53.38%) compared to that in cells treated with a normal glucose concentration of 5.5 mM. However, treatment with 1, 5, 10, or 20 µMof ferulic acid significantly increased the viability rate to 55.73, 77.71, 81.30, and 89.06%, respectively.
Fig. 2. Effect of ferulic acid on the viability of high glucose-treated INS-1 cells. INS-1 cells (2×104 cells/well) are preincubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr and then incubated with ferulic acid (0, 1, 5, 10, or 20 μM) for 48 hr. Here, 5.5 mM and 30 mM of glucose represents normal and high glucose levels, respectively. Each value is expressed as the mean ± SD (n=3). a-fValues with different letters indicate significant differences with p<0.05, as analyzed using Duncan’s multiple-range test.
Effect of ferulic acid on intracellular reactive oxygen species (ROS)
In pancreatic β cells treated with 30 mM high glucose, the level of intracellular ROS was significantly increased by 208.50% compared with cells treated with 5.5 mM normal glucose (Fig. 3). However, following treatment with ferulic acid, ROS levels decreased in a dose-dependent manner. Treatment with 1, 5, 10 and 20 μM ferulic acid significantly reduced high glucose-induced ROS production (201.87, 163.30, 148.60 and 125.24%, respectively). Thus, ferulic acid significantly reduced intracellular ROS excessively produced in response to high glucose levels in pancreatic β cells.
Fig. 3. Effect of ferulic acid on the intracellular levels of ROS in high glucose-treated INS-1 cells. INS-1 cells (2×104 cells/well) are preincubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr and then incubated with ferulic acid (0, 1, 5, 10, or 20 μM) for 48 hr. Here, 5.5 mM and 30 mM of glucose represents normal and high glucose levels, respectively. Each value is expressed as the mean ± SD (n=3). a-eValues with different letters indicate significant differences with p<0.05, as analyzed using Duncan’s multiple-range test.
Effect of ferulic acid on the production of TBARS
The effect of ferulic acid on lipid peroxidation was investigated by measuring the lipid peroxidation product, TBARS (Fig. 4). The TBARS levels in cells treated with normal and high glucose concentrations were 0.14 and 0.29 nmol of MDA, respectively. Treatment with 1, 5, 10, or 20 μM of ferulic acid significantly lowered high-glucose-induced TBARS production to 0.28, 0.25, 0.22, and 0.18 nmol MDA, respectively.
Fig. 4. Effect of ferulic acid on the intracellular levels of TBARS in high glucose-treated INS-1 cells. INS-1 cells (2×104 cells/well) are preincubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr and then incubated with ferulic acid (0, 1, 5, 10, or 20 μM) for 48 hr. Here, 5.5 mM and 30 mM of glucose represents normal and high glucose levels, respectively. Each value is expressed as the mean ± SD (n=3). a-eValues with different letters indicate significant differences with p<0.05, as analyzed by Duncan’s multiple-range test.
Effect of ferulic acid on NO levels
Treatment of INS-1 pancreatic β cells with 30 mM glucose significantly increased NO levels to 264.34% compared with control cells treated with 5.5 mM glucose (Fig. 5). However, cells pretreated with ferulic acid before exposure to 30 mM glucose displayed decreased levels of NO in an ferulic acid dose-dependent manner. The NO production induced by the high glucose concentration in the 1, 5, 10 and 20 μM ferulic acid pretreated cells was 253.27, 215.60, 210.89 and 175.73 %, respectively. Thus, ferulic acid progressively inhibited NO production caused by high glucose.
Fig. 5. Effect of ferulic acid on the intracellular levels of NO in high glucose-treated INS-1 cells. INS-1 cells (2×104 cells/well) are preincubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr and then incubated with ferulic acid (0, 1, 5, 10, or 20 μM) for 48 hr. Here, 5.5 mM and 30 mM of glucose represents normal and high glucose levels, respectively. Each value is expressed as the mean ± SD (n=3). a-eValues with different letters indicate significant differences with p<0.05, as analyzed by Duncan’s multiple-range test.
Effect of ferulic acid on the expression of apoptosis-related proteins
Western blot analysis was performed to determine if ferulic acid alters the expression of genes involved in apoptosis induced by high glucose levels. The levels of Bax, Bcl-2, cytochrome c, caspase 9, and caspase 3 were measured. As shown in Fig. 6, the expression levels of pro-apoptotic Bax, cytochrome c, caspase 9, and caspase 3 were significantly increased in INS-1 pancreatic β cells treated with high glucose. However, the expression levels of anti-apoptotic Bcl-2 were significantly low in cells treated with high glucose. Treatment with 5 or 20 μM ferulic acid significantly decreased the levels of Bax, cytochrome c, caspase 9, and caspase 3 and significantly increased the levels of Bcl-2. The results showed that ferulic acid treatment decreased the expression of proapoptotic proteins and increased the expression of anti-apoptotic proteins in the β cells damaged by high glucose.
Fig. 6. Effect of ferulic acid on the expression of Bax, Bcl-2, cytochrome C, caspase 9, and caspase 3 proteins in high glucose-treated INS-1 cells. INS-1 cells are preincubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr and then incubated with ferulic acid (0, 5, or 20 μM) for 48 hr. Here, 5.5 mM and 30 mM of glucose represents normal and high glucose levels, respectively. Equal amounts of cell lysates were electrophoresed and analyzed for Bax, Bcl-2, cytochrome C, caspase 9, and caspase 3 proteins using western blotting. Actin was used as an internal control. (A) Expression of Bax, Bcl-2, cytochrome C, caspase 9, and caspase 3 proteins (B) Expression of Bax, Bcl-2, cytochrome C, caspase 9, and caspase 3 proteins. Each value is expressed as the mean ± SD (n=3). a-dValues with different letters indicate significant differences with p<0.05, as analyzed by Duncan’s multiple-range test.
Cell apoptosis rate measured by annexin-V/PI staining
After treatment with ferulic acid, the apoptosis rate was assessed in the β cells by flow cytometry using annexin-V/PI staining. Viable cells are shown in the lower left quadrant, and cells in the early and late stages of apoptosis are shown at the bottom and top of the right quadrant, respectively (Fig. 7). Under a high-glucose condition (30 mM), apoptosis levels were significantly increased compared to those under a normal-glucose condition (5.5 mM). However, the addition of 5 or 20 μM ferulic acid reduced the rate of death in cells treated with 30 mM glucose. When the cells were treated with 30 mM glucose alone, the rates of early and late apoptosis significantly increased. However, the rate of early and late cell death was significantly decreased following treatment with 20 μM ferulic acid. The results indicated that ferulic acid protected the β cells from apoptosis caused by high glucose levels.
Fig. 7. Identification of the apoptotic stage of INS-1 cells in response to different treatments using annexin-V/ PI staining. (A) The status of apoptotic cell death is determined by counting INS-1 cells stained with annexin V-FITC/PI using a flow cytometer. Cells are preincubated with glucose and then incubated in the presence or absence of ferulic acid (0, 5, or 20 μM). The right lower and upper quadrants show the numbers of early and late apoptotic cells, respectively. (B) Mean rates of apoptosis. a-dValues with different letters indicate significant differences with p<0.05, as analyzed by Duncan’s multiple-range test.
Effect of ferulic acid on insulin secretion
Fig. 8 shows that the insulin secretion in INS-1 pancreatic β cells was significantly decreased in response to high-glucose (30 mM) treatment compared to that observed with normal-glucose (5.5 mM) treatment. After inducing glucose toxicity by treatment with 30 mM glucose and washing, the insulin secretion ability was analyzed by treatment with 5 or 25 mM glucose. Treatment with ferulic acid restored the 30 mM glucose-induced impairment of insulin secretion with 5 or 25 mM glucose. Treatment of INS-1 pancreatic β cells with 1, 5, 10, and 20 μM ferulic acid increased insulin secretion by 6.48, 11.08, 15.98, and 20.41 ng/hr, respectively in cells incubated with 5 mM glucose (p<0.05). In addition, ferulic acid treatment at 1, 5, 10, and 20 μM concentrations increased insulin secretion by 13.46, 17.71, 19.54, and 24.30 ng/hr in cells incubated with 25 mM glucose (p<0.05). The results indicated that ferulic acid alleviated the insulin secretion reduction in the β cells, induced by high-glucose concentrations.
Fig. 8. Effect of ferulic acid on the insulin secretion in highglucose-treated INS-1 cells. INS-1 cells (2×104 cells/well) are pre-incubated in 96-well plates with 5.5 or 30 mM of glucose for 48 hr. Thereafter, the cells are washed, and the cell culture medium is replaced with fresh medium and further incubated for 5 hr. Subsequently, the cells are incubated with ferulic acid (0, 1, 5, 10, or 20 μM) for 48 hr and stimulated with Krebs-Ringer buffer containing 5 or 25 mM glucose for 60 min. The concentrations of 5.5 mM and 30 mM represent normal and high glucose concentrations, respectively. Each value is expressed as the mean ± SD (n= 3). a-eValues with different letters indicate significant differences with p<0.05, as analyzed by Duncan’s multiple-range test.
Discussion
Pancreatic β cells secrete insulin, an important hormone for maintaining blood glucose homeostasis. Blood-glucose levels are normally maintained by the balance between insulin secretion and action. However, dysfunction of the β cells is a critical factor in the pathogenesis of diabetes as it reduces insulin secretion. In pancreatic β cells, oxidative phosphorylation of glucose produces ROS. The effects of ROS are mitigated by antioxidant enzymes, such as superoxide dismutase and catalase. β cells produce low levels of these enzymes and glutathione peroxidase (a redox-regulating enzyme) and are sensitive to oxidative stress [16, 27]. Under pathological conditions of hyperglycemia, high glucose levels can disrupt glycolysis, and glucose can be metabolized via pathways that produce excessive amounts of ROS in the mitochondria. Excessive ROS production leads to oxidative stress, eventually damaging β cells that produce relatively low levels of antioxidant enzymes, such as catalase and glutathione peroxidase [2]. Reducing oxidative stress attributed to hyperglycemia is important to restore β-cell damage in type 2 diabetes.
Ferulic acid is a hydroxycinnamic acid with low toxicity and numerous physiological functions, including anti-inflammatory, antimicrobial, anticancer, antidiabetic, and immunostimulatory effects [17, 34]. Among these, antioxidant activity has been the most documented [26]. Therefore, we investigated whether ferulic acid protected pancreatic cells from oxidative stress and cell damage caused by high glucose levels. The MTT assay was performed to assess the viability of β cells. High glucose concentrations of 30 mM significantly reduced the viability of β cells. However, ferulic acid significantly restored the cell viability. These results indicated that ferulic acid protected β cells against cytotoxicity attributed to high glucose.
High glucose levels accelerate metabolic reactions leading to excessive ROS production. Excessive ROS levels affect the function and survival of cells by activating signaling pathways that are sensitive to cellular stress [30]. Activation of apoptosis by ROS leads to diabetes and worsens diabetic conditions. Hence, the inhibition of excessive ROS production induced by high glucose concentrations may contribute to alleviating β-cell impairment, thereby preventing the progression of diabetes [19, 29]. When pancreatic β cells were treated with 30 mM of glucose, intracellular ROS levels were significantly increased. However, ferulic acid treatment inhibited this production, resulting in significantly lower ROS levels. This result indicates that ferulic acid may prevent pancreatic cell impairment at high glucose concentrations by lowering ROS production. Ferulic acid belongs to the phenolic acid group and has several functional groups (one hydroxyl and one methoxy group) in its structure [15]. The number and position of hydroxyl groups in phenolic acids are directly related to their free-radical-scavenging ability [25]. When the number of phenolic hydroxyl groups on the benzene ring is less than four, the antioxidant activity of the phenolic acids is proportional to the number of phenolic hydroxyl groups [8]. Hence, the scavenging effects of ferulic acid on ROS may be attributed to the presence of hydroxyl groups in its structure.
Increased ROS levels cause cell-membrane damage via the formation of lipid peroxides and lipid peroxide radicals. Hence, lipid peroxidation may serve as a valuable indicator of impairment in INS-1 pancreatic β cells [6, 21]. Exposure of INS-1 pancreatic β cells to high glucose levels increased the generation of lipid peroxides; however, ferulic acid treatment significantly inhibited lipid-peroxide generation. This result suggests that the inhibition of lipid-peroxide formation may be one of the protective mechanisms involved in the ferulic acid-mediated reduction of high glucose-induced cytotoxicity in INS-1 pancreatic β cells. Lipid peroxidation is mediated by ROS and can induce β-cell dysfunction and reduce insulin secretion [4]. Therefore, the production of TBARS should be prevented, and β-cell malfunction due to oxidative stress should be reduced. Flavonoids can inhibit TBARS production due to their antioxidant activity [23].
Oxidative stress activates apoptotic signal-transduction pathways in many cell types [36]. It also promotes apoptosis by participating in the processes related to the initiation of apoptotic signal transduction. Mitochondria are known to induce apoptosis by releasing cytochrome c into the cytosol, which leads to the assembly of a caspase-activating complex referred to as the apoptosome [10]. Bax is a pro-apoptotic protein that promotes apoptosis, resulting in the release of apoptotic factors from mitochondria. In contrast, Bcl-2 is an anti-apoptotic protein that preserves the integrity of the outer mitochondrial membrane [24]. Changes in the expression of these genes can further stimulate apoptotic events, including changes in the mitochondria, which ultimately lead to the activation of a family of cysteine proteases called caspases [22]. Among these, caspase 3 and caspase 9 are frequently activated death proteases that catalyze the specific cleavage of many key cellular proteins [20]. In this study, high glucose levels induced the release of apoptogenic factors via activation of the mitochondrial apoptotic pathway in INS-1 pancreatic β cells. However, ferulic acid treatment markedly reduced Bax expression, increased Bcl-2 expression, and significantly decreased the levels of cytochrome c, caspase 3, and caspase 9.
In some studies, the hydroxyl groups of compounds isolated from plants have exhibited anti-apoptotic effects and are involved in the regulation of mitochondrial apoptotic pathways [14, 33]. The anti-apoptotic effect of the hydroxyl group is related to the inhibition of intracellular ROS and lipid peroxidation. Particularly, the hydroxyl group in foodderived polyphenols helps scavenge free radicals and is considered to contribute to their antioxidant activity [18, 35]. Polyphenolic hydroxyl groups release active hydrogen atoms to block lipid autoxidation and regulate mitochondrial membranes to maintain the levels of apoptotic and anti-apoptotic proteins [32, 35]. Ferulic acid has one hydroxyl group at the C-4 position of the benzene ring. Hence, we hypothesized that the hydroxyl group in ferulic acid might contribute to its anti-apoptotic effect in INS-1 pancreatic β cells. This study suggested that ferulic acid protects INS-1 pancreatic β cells from apoptosis induced by high glucose levels. This effect was confirmed by the increased anti-apoptotic Bcl-2 expression and decreased expression of pro-apoptotic Bax, cytochrome c, caspase 9, and caspase 3.
Flow cytometry was performed to examine the rate of cell death using annexin V as a marker [31]. After treatment with high glucose, cells in the pancreas showed an increased rate of cell death; however, ferulic acid markedly decreased the number of apoptotic cells. This result indicates that ferulic acid can protect the β cells from hyperglycemia-mediated cell death. Hyperglycemia-induced damage to pancreatic cells can lead to insulin-secretion deficiency [13]. In this study, insulin secretion markedly decreased in cells treated with high glucose at a concentration of 30 mM. However, treatment with ferulic acid significantly increased insulin secretion. These results imply that ferulic acid could protect pancreatic β cells and restore their insulin-secretion capacity.
In conclusion, treatment with high glucose (30 mM) concentrations increased the ROS, TBARS, and NO levels. As a result, apoptosis increased and insulin secretion decreased. However, ferulic acid treatment protected the β cells of pancreas from the effects of high glucose concentration by lowering cell death, which significantly restored the level of insulin secretion. Our results demonstrated the efficacy of ferulic acid in protecting cells from glucotoxicity and preventing the progression of diabetes. Hence, ferulic acid shows promise as a pharmaceutical agent that protects cells from hyperglycemia-induced apoptosis.
Acknowledgement
This work was supported by a 2-year research grant from Pusan National University.
The Conflict of Interest Statement
The authors declare that they have no conflicts of interest with the contents of this article.
References
- American Diabetes Association. 2009. Diagnosis and classification of diabetes mellitus. Diabetes Care 32, 62-67.
- Bhattacharyya, A., Chattopadhyay, R., Mitra, S. and Crowe, S. E. 2014. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol. Rev. 94, 329-354. https://doi.org/10.1152/physrev.00040.2012
- Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., and Reddy, P. H. 2022. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic. Biol. Med. 184, 114-134. https://doi.org/10.1016/j.freeradbiomed.2022.03.019
- Blesia, V., Patel, V. B., Al Obaidi, H., Renshaw, D. and Zariwala, M. G. 2021. Excessive Iron induces oxidative stress promoting cellular perturbations and insulin secretory dysfunction in MIN6 beta cells. Cells 10, 1141.
- Cerf M. E. 2013. Beta cell dysfunction and insulin resistance. Front. Endocrinol. (Lausanne) 4, 37.
- Chikezie, P. C., Ojiako, O. A. and Ogbuji, A. C. 2015. Oxidative stress in diabetes mellitus. Int. J. Biol. Chem. 9, 92-109. https://doi.org/10.3923/ijbc.2015.92.109
- De Oliveira Silva, E., and Batista, R. 2017. Ferulic acid and naturally occurring compounds bearing a feruloyl moiety: A review on their structures, occurrence, and potential health benefits. Compr. Rev. Food Sci. Food Saf. 16, 580-616. https://doi.org/10.1111/1541-4337.12266
- Farhoosh, R., Johnny, S., Asnaashari, M., Molaahmadibahraseman, N. and Sharif, A. 2016. Structure-AA relationships of o-hydroxyl, o-methoxy, and alkyl ester derivatives of p-hydroxybenzoic acid. Food Chem. 194, 128-134. https://doi.org/10.1016/j.foodchem.2015.08.003
- Galicia Garcia, U., Benito Vicente, A. and Jebari S. 2020. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21, 6275.
- Garrido, C., Galluzzi, L., Brunet, M., Puig, P. E., Didelot, C., and Kroemer, G. 2006. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13, 1423-1433. https://doi.org/10.1038/sj.cdd.4401950
- Gupta, A., Singh, A. K., Loka, M., Pandey, A. K. and Bishayee, A. 2021. Ferulic acid-mediated modulation of apoptotic signaling pathways in cancer. Adv. Protein Chem. Struct. Biol. 125, 215-257. https://doi.org/10.1016/bs.apcsb.2020.12.005
- Kannan, K. and Jain, S. K. 2000. Oxidative stress and apoptosis. Pathophysiology 7, 153-163. https://doi.org/10.1016/S0928-4680(00)00053-5
- Kasuga, M. 2006. Insulin resistance and pancreatic beta cell failure. J. Clin. Invest. 116, 1756-1760. https://doi.org/10.1172/JCI29189
- Kim, K. H., Kim, Y. W., Kim, H. B., Lee, B. J. and Lee, D. S. 2006. Anti-apoptotic activity of laminarin polysaccharides and their enzymatically hydrolyzed oligosaccharides from Laminaria japonica. Biotechnol. Lett. 28, 439-446. https://doi.org/10.1007/s10529-005-6177-9
- Kulik, T., Nastasiienko, N., Palianytsia, B., Ilchenko, M. and Larsson, M. 2021. Catalytic pyrolysis of lignin model compound (Ferulic Acid) over alumina: surface complexes, kinetics, and mechanisms. Catalysts 11, 1508.
- Lei, X. G. and Vatamaniuk, M. Z. 2011. Two tales of antioxidant enzymes on β cells and diabetes. Antioxid. Redox. Signal. 14, 489-503. https://doi.org/10.1089/ars.2010.3416
- Mancuso, C. and Santangelo, R. 2014. Ferulic acid: pharmacological and toxicological aspects. Food Chem. Toxicol. 65, 185-195. https://doi.org/10.1016/j.fct.2013.12.024
- Mouria, M., Gukovskaya, A.S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A. and Pandol, S. J. 2002. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 98, 761-769. https://doi.org/10.1002/ijc.10202
- Newsholme, P., Haber, E. P., Hirabara, S. M., Rebelato, E. L., Procopio, J., Morgan, D., Oliveira Emilio, H. C., Carpinelli, A. R. and Curi, R. 2007. Diabetes associated cell stress and dysfunction: role of mitochondrial and nonmitochondrial ROS production and activity. J. Physiol. 583, 9-24. https://doi.org/10.1113/jphysiol.2007.135871
- Parrish, A. B., Freel, C. D. and Kornbluth, S. 2013. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol. 5, a008672.
- Pi, J., Bai, Y., Zhang, Q., Wong, V., Floering, L. M., Daniel, K. and Collins, S. 2007. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56, 1783-1791. https://doi.org/10.2337/db06-1601
- Robertson, J. D., Gogvadze, V., Kropotov, A., Vakifahmetoglu, H., Zhivotovsky, B. and Orrenius, S. 2004. Processed caspase-2 can induce mitochondria-mediated apoptosis independently of its enzymatic activity. EMBO Rep. 5, 643-648. https://doi.org/10.1038/sj.embor.7400153
- Safari, M. R. and Sheikh, N. 2003. Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification. Prostaglandins Leukot Essent Fatty Acids 69, 73-77. https://doi.org/10.1016/S0952-3278(03)00085-1
- Shamas Din, A., Kale, J., Leber, B. and Andrews, D. W. 2013. Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol. 5, a008714.
- Siquet, C., Paiva Martins, F., Lima, J. L. F. C., Reis, S. and Borges, F. 2006. Antioxidant profile of dihydroxyand trihydroxyphenolic acids-a structure-activity relationship study. Free Radical. Res. 40, 433-442. https://doi.org/10.1080/10715760500540442
- Srinivasan, M., Sudheer, A. R. and Menon, V. P. 2007. Ferulic Acid: therapeutic potential through its antioxidant property. J. Clin. Biochem. Nutr. 40, 92-100. https://doi.org/10.3164/jcbn.40.92
- Stancill, J. S. and Corbett, J. A. 2021. The role of Thioredoxin/Peroxiredoxin in the β-cell defense against oxidative damage. Front. Endocrinol. (Lausanne) 12, 718235.
- Tangvarasittichai, S. 2015. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J. Diabetes. 6, 456-80. https://doi.org/10.4239/wjd.v6.i3.456
- Volpe, C. M. O., Villar Delfino, P. H., Dos Anjos, P. M. F. and Nogueira Machado, J. A. 2018. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 25, 119.
- Wang, C., Zhang, Y., Li, F. and Wei, Y. 2019. Conserved roles of glucose in suppressing reactive oxygen species-induced cell death and animal survival. Aging (Albany NY). 11, 5726-5743. https://doi.org/10.18632/aging.102155
- Wlodkowic, D., Skommer, J. and Darzynkiewicz, Z. 2009. Flow cytometry-based apoptosis detection. Methods Mol. Biol. 559, 19-32. https://doi.org/10.1007/978-1-60327-017-5_2
- Xiimardan, G. 2009. Several herbs todal flavonoid contents determination. J. Xinjiang Norm. Univ. 28, 73-88.
- Ye, B. R., Kim, J. S., Kim, M. S., Jang, J. Y., Oh, C. H., Kang, D. H., Qian, Z. J., Jung, W. K., Choi, I. W. and He, S. J. 2013. Induction of apoptosis by the tropical seaweed Pylaiella littoralis in HT-29 cells via the mitochondrial and MAPK pathways. Ocean Sci. 48, 339-348. https://doi.org/10.1007/s12601-013-0032-z
- Zdunska, K., Dana, A., Kolodziejczak, A. and Rotsztejn, H. 2018. Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol. Physiol. 31, 332-336. https://doi.org/10.1159/000491755
- Zhang, R., Kang, K. A., Kang, S. S., Park, J. W. and Hyun, J. W. 2011. Morin (29,3,49,5,7-pentahydroxyflavone) protected cells against c-radiation-induced oxidative stress. Basic Clin. Pharmacol. Toxicol. 108, 63-72. https://doi.org/10.1111/j.1742-7843.2010.00629.x
- Zhou, Y., Wang, Q., Evers, B. M., and Chung, D. H. 2005. Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis. Pediatric. research 58, 1192-1197. https://doi.org/10.1203/01.pdr.0000185133.65966.4e
- Zorov, D. B., Juhaszova, M. and Sollott, S. J. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909-950. https://doi.org/10.1152/physrev.00026.2013